(Q43550287)

24 November 2017

title

Liver cell dysplasia and hepatocellular carcinoma: a histological and immunohistochemical study (English)

1 reference

24 November 2017

1 reference

hepatocellular carcinoma

1 reference

Roncalli M

1

1 reference

24 November 2017

Borzio M

2

1 reference

24 November 2017

de Biagi G

3

1 reference

24 November 2017

Servida E

4

1 reference

24 November 2017

Cantaboni A

5

1 reference

24 November 2017

Sironi M

6

1 reference

24 November 2017

Taccagni GL

7

1 reference

24 November 2017

publication date

1 February 1985

1 reference

24 November 2017

1 reference

24 November 2017

volume

9

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

209-221

1 reference

Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1985.TB02436.X

Primary carcinoma of the liver: a study of 282 cases in Ugandan Africans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1985.TB02436.X

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1985.TB02436.X

Liver cell dysplasia.Association with hepatocellular carcinoma, cirrhosis and hepatitis B antigen carrier status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1985.TB02436.X

Immunohistopathologic study on carcinoembryonic antigen (CEA)-like material and immunoglobulin a in gastric malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1985.TB02436.X

Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in Hong Kong: a necropsy study: 1963-1976

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1985.TB02436.X

Liver cell dysplasia in association with hepatocellular carcinoma, cirrhosis and hepatitis B surface antigen in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1985.TB02436.X

Hepatitis B surface antigen and hepatocellular carcinoma in the people's Republic of China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1985.TB02436.X

Hepatitis-B surface antigen in tumour tissue and non-tumorous liver in black patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1985.TB02436.X

Sequential analysis of hepatic carcinogenesis: the comparative architecture of preneoplastic, malignant, prenatal, postnatal and regenerating liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1985.TB02436.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1985.TB02436.X

Hepatitis B and primary hepatocellular carcinoma in a European population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1985.TB02436.X

Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1985.TB02436.X

10.1111/J.1365-2559.1985.TB02436.X

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference